Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10959693rdf:typepubmed:Citationlld:pubmed
pubmed-article:10959693lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10959693lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:10959693lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:10959693lifeskim:mentionsumls-concept:C0164707lld:lifeskim
pubmed-article:10959693lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:10959693pubmed:issue2lld:pubmed
pubmed-article:10959693pubmed:dateCreated2000-11-27lld:pubmed
pubmed-article:10959693pubmed:abstractTextIncreased plasma concentrations of various markers of endothelial damage have been observed in type I diabetic patients, particularly in those with microangiopathy.lld:pubmed
pubmed-article:10959693pubmed:languageenglld:pubmed
pubmed-article:10959693pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10959693pubmed:citationSubsetIMlld:pubmed
pubmed-article:10959693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10959693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10959693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10959693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10959693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10959693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10959693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10959693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10959693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10959693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10959693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10959693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10959693pubmed:statusMEDLINElld:pubmed
pubmed-article:10959693pubmed:monthAuglld:pubmed
pubmed-article:10959693pubmed:issn0340-6245lld:pubmed
pubmed-article:10959693pubmed:authorpubmed-author:de LeivaAAlld:pubmed
pubmed-article:10959693pubmed:authorpubmed-author:PérezAAlld:pubmed
pubmed-article:10959693pubmed:authorpubmed-author:FontcubertaJJlld:pubmed
pubmed-article:10959693pubmed:authorpubmed-author:MaterMMlld:pubmed
pubmed-article:10959693pubmed:authorpubmed-author:SoutoJ CJClld:pubmed
pubmed-article:10959693pubmed:authorpubmed-author:RiglaMMlld:pubmed
pubmed-article:10959693pubmed:issnTypePrintlld:pubmed
pubmed-article:10959693pubmed:volume84lld:pubmed
pubmed-article:10959693pubmed:ownerNLMlld:pubmed
pubmed-article:10959693pubmed:authorsCompleteYlld:pubmed
pubmed-article:10959693pubmed:pagination223-7lld:pubmed
pubmed-article:10959693pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:meshHeadingpubmed-meshheading:10959693...lld:pubmed
pubmed-article:10959693pubmed:year2000lld:pubmed
pubmed-article:10959693pubmed:articleTitleNormalisation of tissue factor pathway inhibitor activity after glycaemic control optimisation in type 1 diabetic patients.lld:pubmed
pubmed-article:10959693pubmed:affiliationDepartment of Endocrinology and Nutrition, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Spain.lld:pubmed
pubmed-article:10959693pubmed:publicationTypeJournal Articlelld:pubmed